Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMS-770767 in Type 2 Diabetes
NCT01046422Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- May 2010
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of BMS-770767 in type 2 diabetes mellitus (T2DM), sponsored by Bristol Myers Squibb. Started May 2010; status: completed.
02
Drugs
BMS-770767
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01046422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01046422.